307 related articles for article (PubMed ID: 26857699)
1. Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease.
Michaud K; Berglind N; Franzén S; Frisell T; Garwood C; Greenberg JD; Ho M; Holmqvist M; Horne L; Inoue E; Nyberg F; Pappas DA; Reed G; Symmons D; Tanaka E; Tran TN; Verstappen SM; Wesby-van Swaay E; Yamanaka H; Askling J
Ann Rheum Dis; 2016 Oct; 75(10):1797-805. PubMed ID: 26857699
[TBL] [Abstract][Full Text] [Related]
2. How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries.
Askling J; Berglind N; Franzen S; Frisell T; Garwood C; Greenberg JD; Ho M; Holmqvist M; Horne L; Inoue E; Michaud K; Nyberg F; Pappas DA; Reed G; Tanaka E; Tran TN; Verstappen SM; Yamanaka H; Wesby-van Swaay E; Symmons D
Ann Rheum Dis; 2016 Oct; 75(10):1789-96. PubMed ID: 26621482
[TBL] [Abstract][Full Text] [Related]
3. Methodological Challenges When Comparing Demographic and Clinical Characteristics of International Observational Registries.
Verstappen SM; Askling J; Berglind N; Franzen S; Frisell T; Garwood C; Greenberg JD; Holmqvist M; Horne L; Lampl K; Michaud K; Nyberg F; Pappas DA; Reed G; Symmons DP; Tanaka E; Tran TN; Yamanaka H; Ho M
Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1637-45. PubMed ID: 26201948
[TBL] [Abstract][Full Text] [Related]
4. Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programme.
Yamanaka H; Askling J; Berglind N; Franzen S; Frisell T; Garwood C; Greenberg JD; Ho M; Holmqvist M; Novelli Horne L; Inoue E; Michaud K; Pappas DA; Reed G; Symmons D; Tanaka E; Tran TN; Verstappen SMM; Wesby-van Swaay E; Nyberg F
RMD Open; 2017; 3(2):e000498. PubMed ID: 29081988
[TBL] [Abstract][Full Text] [Related]
5. Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach.
Nyberg F; Askling J; Berglind N; Franzén S; Ho M; Holmqvist M; Horne L; Lampl K; Michaud K; Pappas DA; Reed G; Symmons D; Tanaka E; Tran TN; Verstappen SM; Wesby-van Swaay E; Yamanaka H; Greenberg JD
Pharmacoepidemiol Drug Saf; 2015 Nov; 24(11):1121-32. PubMed ID: 26303866
[TBL] [Abstract][Full Text] [Related]
6. Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study.
Solomon DH; Greenberg J; Curtis JR; Liu M; Farkouh ME; Tsao P; Kremer JM; Etzel CJ
Arthritis Rheumatol; 2015 May; 67(8):1995-2003. PubMed ID: 25989470
[TBL] [Abstract][Full Text] [Related]
7. Incidence and Predictors of Biological Antirheumatic Drug Discontinuation Attempts among Patients with Rheumatoid Arthritis in Remission: A CORRONA and NinJa Collaborative Cohort Study.
Yoshida K; Radner H; Mjaavatten MD; Greenberg JD; Kavanaugh A; Kishimoto M; Matsui K; Okada M; Reed G; Saeki Y; Tohma S; Kremer J; Solomon DH
J Rheumatol; 2015 Dec; 42(12):2238-46. PubMed ID: 26523025
[TBL] [Abstract][Full Text] [Related]
8. Long-term mortality rate in rheumatoid arthritis patients with disease onset in the 1980s.
Kapetanovic MC; Lindqvist E; Geborek P; Saxne T; Eberhard K
Scand J Rheumatol; 2011 Nov; 40(6):433-8. PubMed ID: 21619489
[TBL] [Abstract][Full Text] [Related]
9. Linkage of a de-identified United States rheumatoid arthritis registry with administrative data to facilitate comparative effectiveness research.
Curtis JR; Chen L; Bharat A; Delzell E; Greenberg JD; Harrold L; Kremer J; Setoguchi S; Solomon DH; Xie F; Yun H
Arthritis Care Res (Hoboken); 2014 Dec; 66(12):1790-8. PubMed ID: 24905637
[TBL] [Abstract][Full Text] [Related]
10. TNF antagonist safety in rheumatoid arthritis: updated evidence from observational registries.
Nasir A; Greenberg JD
Bull NYU Hosp Jt Dis; 2007; 65(3):178-81. PubMed ID: 17922666
[TBL] [Abstract][Full Text] [Related]
11. Rheumatoid arthritis registries in Sweden.
van Vollenhoven RF; Askling J
Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S195-200. PubMed ID: 16273807
[TBL] [Abstract][Full Text] [Related]
12. A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries.
Curtis JR; Jain A; Askling J; Bridges SL; Carmona L; Dixon W; Finckh A; Hyrich K; Greenberg JD; Kremer J; Listing J; Michaud K; Mikuls T; Shadick N; Solomon DH; Weinblatt ME; Wolfe F; Zink A
Semin Arthritis Rheum; 2010 Aug; 40(1):2-14.e1. PubMed ID: 20674669
[TBL] [Abstract][Full Text] [Related]
13. Tofacitinib, an oral Janus kinase inhibitor, for the treatment of Latin American patients with rheumatoid arthritis: Pooled efficacy and safety analyses of Phase 3 and long-term extension studies.
Radominski SC; Cardiel MH; Citera G; Goecke A; Jaller JJ; Lomonte ABV; Miranda P; Velez P; Xibillé D; Kwok K; Rojo R; García EG
Reumatol Clin; 2017; 13(4):201-209. PubMed ID: 27317492
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study.
Pappas DA; Nyberg F; Kremer JM; Lampl K; Reed GW; Horne L; Ho M; Onofrei A; Malaviya AN; Rillo OL; Radominski SC; Gal J; Gibofsky A; Popkova TV; Laurindo L; Kerzberg EM; Zahora R; Pons-Estel BA; Curtis JR; Furst DE; Greenberg JD
Clin Rheumatol; 2018 Sep; 37(9):2331-2340. PubMed ID: 29696436
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real-life evidence from BioSTAR nationwide registry.
Duruöz MT; Ataman Ş; Bodur H; Çay HF; Melikoğlu MA; Akgül Ö; Çapkın E; Gürer G; Çevik R; Göğüş FN; Kamanlı A; Yurdakul FG; Yağcı İ; Rezvani A; Altan L
Rheumatol Int; 2024 Feb; 44(2):291-301. PubMed ID: 38157014
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous nodules are associated with cardiovascular events in patients with rheumatoid arthritis: results from a large US registry.
Kaushik P; Solomon DH; Greenberg JD; Anderson JT; Reed G; Pala O; Sumbul-Yuksel B; Kadam P; Kremer JM;
Clin Rheumatol; 2015 Oct; 34(10):1697-704. PubMed ID: 26242470
[TBL] [Abstract][Full Text] [Related]
17. Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment.
Simon TA; Smitten AL; Franklin J; Askling J; Lacaille D; Wolfe F; Hochberg MC; Qi K; Suissa S
Ann Rheum Dis; 2009 Dec; 68(12):1819-26. PubMed ID: 19054822
[TBL] [Abstract][Full Text] [Related]
18. Higher education is associated with a better rheumatoid arthritis outcome concerning for pain and function but not disease activity: results from the EIRA cohort and Swedish rheumatology register.
Jiang X; Sandberg ME; Saevarsdottir S; Klareskog L; Alfredsson L; Bengtsson C
Arthritis Res Ther; 2015 Nov; 17():317. PubMed ID: 26546562
[TBL] [Abstract][Full Text] [Related]
19. Treatment of early rheumatoid arthritis in a multinational inception cohort of Latin American patients: the GLADAR experience.
Cardiel MH; Pons-Estel BA; Sacnun MP; Wojdyla D; Saurit V; Marcos JC; Pinto MR; Cordeiro de Azevedo AB; da Silveira IG; Radominski SC; Ximenes AC; Massardo L; Ballesteros F; Rojas-Villarraga A; Oñate RV; Hernandez MP; Esquivel-Valerio JA; García-De La Torre I; Khoury VJ; Millán A; Soriano ER;
J Clin Rheumatol; 2012 Oct; 18(7):327-35. PubMed ID: 23047532
[TBL] [Abstract][Full Text] [Related]
20. Rheumatoid arthritis patients treated in trial and real world settings: comparison of randomized trials with registries.
Kilcher G; Hummel N; Didden EM; Egger M; Reichenbach S;
Rheumatology (Oxford); 2018 Feb; 57(2):354-369. PubMed ID: 29149289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
